Know Cancer

or
forgot password

TARGeted Intraoperative radioTherapy With the INTRABEAM-System as an Advanced Boost in Patients With Breast Cancer - A Quality Control Registry in Germany (TARGIT BQR)


N/A
18 Years
85 Years
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

TARGeted Intraoperative radioTherapy With the INTRABEAM-System as an Advanced Boost in Patients With Breast Cancer - A Quality Control Registry in Germany (TARGIT BQR)


Inclusion Criteria:



- Tumor diameter < 3,5 cm

- Informed consent

Exclusion Criteria:

- No informed consent

- Tumor size > 3,5 cm

- No indication for a boost

Type of Study:

Observational

Study Design:

Observational Model: Ecologic or Community, Time Perspective: Prospective

Outcome Measure:

Local recurrence rate

Outcome Time Frame:

5 years

Safety Issue:

Yes

Principal Investigator

Frederik Wenz, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital Mannheim

Authority:

Germany: Ethics Commission

Study ID:

TARGIT BQR

NCT ID:

NCT01440010

Start Date:

September 2011

Completion Date:

Related Keywords:

  • Breast Cancer
  • IORT
  • Boost
  • Breast cancer
  • Local recurrence
  • Toxicity
  • LENT SOMA
  • TARGIT
  • Quality Control Registry
  • Breast Neoplasms

Name

Location